|
| Press Releases |
|
 |
|
| Friday, September 23, 2022 |
|
|
Malaysian Genomics Grows Presence in Thailand |
| Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, is pleased to announce today a series of collaborations to grow its customer base in Thailand as well as exploring opportunities for research and development (R&D) of new products and services. more info >> |
|
| Wednesday, September 21, 2022 |
|
|
Malaysian Genomics, Rinani Genotec Sign LOI with Universiti Malaysia Sabah |
| Leading genomics and biopharmaceutical specialist Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155) is pleased to report that the Group has signed a letter of intent (LOI) with the Faculty of Science and Natural Resources, Universiti Malaysia Sabah (UMS) and Rinani Genotec Sdn Bhd (Genotec) to collaborate on research and development (R&D) in genetics, and regenerative and alternative medicines. more info >> |
|
| Tuesday, August 30, 2022 |
|
|
Malaysian Genomics Reports RM28.36 Million Full-Year Revenue |
| Malaysian Genomics Resource Centre Berhad, a leading genomics and biopharmaceutical specialist, reported revenue of RM6.33 million for the fourth quarter ended 30 June 2022 (4Q 2022) compared with the loss of RM0.07 million in the corresponding quarter of the previous financial year (4Q 2021) on higher contribution from the biopharmaceutical business and continued organic growth of the genetic testing business. more info >> |
|
| Monday, August 29, 2022 |
|
|
Malaysian Genomics Signs MoU with Ajlan to explore distribution of biopharmaceutical and genetic screening services in MENA region |
| Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, today announced that the Group has signed a Memorandum of Understanding (MoU) to explore opportunities for the distribution of biopharmaceutical and genomics products and services with Ajlan & Bros Medical Company. more info >> |
|
| Thursday, August 18, 2022 |
|
|
Malaysian Genomics Explores Strategic Partnership with MAHSA Health through MoU |
| Malaysian Genomics Resource Centre Berhad's (Bursa: MGRC, 0155) wholly-owned subsidiary, MGRC Therapeutics Sdn. Bhd. signed a memorandum of understanding (MoU) with MAHSA Health Sdn Bhd to discuss the formation of a strategic partnership promoting practice-based education, research and knowledge exchange. more info >> |
|
| Wednesday, July 20, 2022 |
|
|
UCrest Partners with Malaysian Genomics to Digitalize Genome Services Worldwide |
| UCrest Berhad (ACE Market: 0005) and Malaysian Genomics Resources Centre Berhad, (ACE Market: 0155) announced today that they have signed a collaborative agreement to integrate genomic testing services into digital health platform, iMedic(TM), elevating healthcare services to the next level. more info >> |
|
| Friday, July 15, 2022 |
|
|
Malaysian Genomics Appoints New Chairman |
| Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, announced today that the Company has appointed Dato' Seri Dr Chen Chaw Min as the Independent Non-Executive Chairman of the Board of Directors. more info >> |
|
| Wednesday, July 13, 2022 |
|
|
Malaysian Genomics Forms Partnership for Expansion in Saudi Arabia |
| Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, announced today that it has entered into a strategic partnership with United Doctors Hospital (UDH) for collaboration in genomics and cell therapies. more info >> |
|
| Friday, July 8, 2022 |
|
|
Malaysian Genomics Proposes Private Placement |
| Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, announced today that the Group is proposing to undertake a private placement of up to 10% of its total number of issued shares or up to 12.42 million new placement shares at an issue price to be determined for third-party investors that will be identified later. more info >> |
|
| Wednesday, July 6, 2022 |
|
|
Malaysian Genomics to Offer First-Ever Sports-Based Tests Specific to Southeast Asian Genetic Profiles |
| Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, is pleased to announce that the Group's wholly-owned subsidiary, MGRC Therapeutics Sdn Bhd (MGRCT), is collaborating with Rinani Genotec Sdn Bhd (Genotec) to offer sports-based genetic tests. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
中國新城鎮2025年內溢利大增35.5% 持續派息回饋股東
Mar 23, 2026 11:32 HKT/SGT
|
|
|
中国新城镇2025年内溢利大增35.5% 持续派息回馈股东
Mar 23, 2026 11:10 HKT/SGT
|
|
|
Results from Real-World, Long-Term Treatment Persistence with LEQEMBI(R) (lecanemab-irmb) in the United States Presented at AD/PD(TM) 2026
Mar 23, 2026 11:19 JST
|
|
|
宇樹科技IPO點燃具身智能行情 首程控股（0697.HK）迎來「投資兌現+平台重估」雙重催化
Mar 23, 2026 09:12 HKT/SGT
|
|
|
宇树科技IPO点燃具身智能行情 首程控股（0697.HK）迎来"投资兑现+平台重估"双重催化
Mar 23, 2026 08:47 HKT/SGT
|
|
|
Unitree Robotics IPO Ignites Embodied-Intelligence Rally, Shoucheng Holdings (0697.HK) Faces a Dual Catalyst of 'Investment Realisation+Platform Re-Rating'
Mar 23, 2026 08:22 HKT/SGT
|
|
|
AEM and ASE Enter Strategic Partnership to Accelerate AI and HPC Test Innovation
Mar 23, 2026 08:00 HKT/SGT
|
|
|
百年金字招牌煥新顏：同仁堂醫養啟動招股 四大投資邏輯錨定"中醫醫療服務龍頭"
Mar 20, 2026 22:21 HKT/SGT
|
|
|
百年金字招牌焕新颜：同仁堂医养启动招股 四大投资逻辑锚定"中医医疗服务龙头"
Mar 20, 2026 22:21 HKT/SGT
|
|
|
FILMART and EntertainmentPulse draw about 8,000 industry participants
Mar 20, 2026 21:40: JST
|
|
|
FILMART and EntertainmentPulse draw about 8,000 industry participants
Mar 20, 2026 20:40 HKT/SGT
|
|
|
康哲藥業業績拐點確立：創新藥與獨家藥接棒增長 新藥進入密集兌現期
Mar 20, 2026 20:08 HKT/SGT
|
|
|
TANAKA Announces Executive Appointments
Mar 20, 2026 20:00 HKT/SGT
|
|
|
127家醫療企業排隊赴港 同仁堂醫養攜連年穩增營收開啟招股
Mar 20, 2026 18:15 HKT/SGT
|
|
|
127家医疗企业排队赴港 同仁堂医养携连年稳增营收开启招股
Mar 20, 2026 18:15 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
